The American Optometric Association (AOA) has issued a consumer alert urging individuals to consult their local optometrists before using or purchasing over-the-counter (OTC) eye drops, particularly MSM eye drops that claim to change eye color. This alert comes in the wake of ongoing concerns following an FDA-issued warning regarding potential contamination in certain MSM eye […]
Read MoreRecent testing has confirmed that India’s Global Pharma Healthcare Ltd. eye drops are free from contamination, following previous links to an outbreak of eye infections in the USA in 2023. This finding comes from reports by NDTV, which cite sources within India’s health ministry after a comprehensive investigation by the drug regulatory authority. Investigative Findings […]
Read MoreAmazon has announced it will cease the sale of seven brands of eyedrops following a warning from the U.S. Food and Drug Administration (FDA). The FDA’s letter to Amazon’s CEO, Andrew Jassy, highlighted that these products were being sold as “unapproved new drugs” on the platform, violating federal regulations. The FDA’s concerns stem from the […]
Read MoreTwo dogs treated at a New Jersey veterinary hospital last year tested positive for a rare, drug-resistant strain of bacteria. This strain, linked to a fatal outbreak in humans caused by now-recalled eye drops, was identified by a CDC investigator. The bacteria, known as carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa, was found in swabs from the lungs […]
Read MoreThe outbreak of eye infections linked to contaminated eye drops in the United States has caused significant concern and action from health authorities. This detailed timeline follows the unfolding events that led to the involvement of the FDA and CDC and the subsequent recalls of various eye drop products. From the initial identification of the […]
Read MoreThe safety of consumers is paramount in the pharmaceutical industry, and the U.S. Food and Drug Administration (FDA) plays a crucial role in ensuring that medical products meet high standards. One of the mechanisms the FDA uses to protect public health is the voluntary recall process. Recently, this process was prominently featured in the recall […]
Read MoreDozens of eye drops and ointments have been pulled from store shelves after a wave of recalls in 2023 and 2024, raising concerns about whether products used to relieve dry or irritated eyes are safe. Most recently, Brassica Pharma voluntarily pulled four eye ointments from stores including Walmart and CVS. This happened after the Food […]
Read MoreOn February 3, 2024, the Food and Drug Administration (FDA) issued a critical warning to consumers, urging them not to purchase or use below mentioned eye drops due to the significant risk of eye infection. This cautionary advisory was prompted by the FDA’s commitment to ensuring the safety and well-being of the general public. The […]
Read MoreThe FDA has ordered certain eye ointment products sold at major retailers including Walmart and CVS to be recalled due to infection risks. After thorough research and investigations, these products have been found to harbor harmful pseudomonas aeruginosa bacteria, posing a serious risk of eye infections. The recall affects a range of ointments used to […]
Read MoreThe Harvard Drug Group, LLC complied with a request by the FDA and undertook a voluntary nationwide recall of certain Rugby Laboratories Brand Eye Drops that were supplied by Velocity Pharma, LLC, because of a potential risk of eye infections. This recall was initiated by The Harvard Drug Group, LLC d/b/a Major® Pharmaceutical and Rugby® […]
Read MoreAn outbreak of infections caused by drug-resistant bacteria that have led to significant health concerns across the United States came from multiple eye drop products: The FDA has identified bacterial and fungal contamination in these products: Notably, both products contain methylsulfonylmethane (MSM) as their active ingredient, a substance not commonly found in legally marketed eye […]
Read MoreThe world of pharmaceuticals is often marred by controversies and recalls, leading to false accusations and widespread concern among consumers. Highlighting the importance of vigilance and rigorous standards prior to coming to conclusions and assigning blame. Media outlets bear a significant responsibility in ensuring their reporting is accurate, fair, and balanced. When they cast blame […]
Read MoreOn March, 2023, additional eyedrop products were flagged for potential safety concerns, prompting widespread alarm among consumers and healthcare professionals alike. The public outcry was swift and intense as news of the additional recalls spread. Many questioned the manufacturing processes of these companies, with evidence mounting that these companies and manufacturers could be the root […]
Read MoreThe Indian drug regulator, in its thorough investigation into the widely publicized multistate outbreak of an extensively drug-resistant bacterium strain linked to various infections, has found no contaminants in the eye drops manufactured by Chennai-based Global Pharma Healthcare. Control samples collected from the manufacturing plant near Chennai by the Indian drug regulator were scrutinized, and […]
Read More